UPDATE 2-Express Scripts drops Amgen anemia drugs from formulary

August 1, 2014 11:46 PM

13 0

Aug 1 (Reuters) - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, said on Friday it will remove an additional 25 products from its list of preferred drugs in 2015, including anemia drugs Epogen and Aranesp, sold by Amgen Inc.

But it will still cover Procrit, a similar anemia drug sold by Johnson & Johnson, on the list, known as a formulary.

Also read: Merck's antiviral drug meets main goal in late-stage trial

Read more

To category page